PSA Rising - welcome!
powered by FreeFind
  • PSA Rising Home | blog latest entry| newswire | forums | books | about
  • Daily Entries
November 2006
S M T W T F S
« Oct    
 1234
567891011
12131415161718
19202122232425
2627282930  
  • TOPICS
    • Prostate Cancer
    • Provenge
    • Taxotere
    • Nutrition
    • Drug Info
    • Satraplatin
    • Activism
    • Jobs, Work, Disability
    • QOL
    • Fatigue
    • Legal issues
    • COX-2 inhibitors
    • Health Insurance
    • Imclone - Erbitux
    • Cancer
    • Vitamin D3
    • African American Cancer Disparities
    • Medical Ethics
    • Pollution
    • Thalidomide
    • Death & Dying
    • Avastin
    • ED
    • Treatment choice
    • Proton beam
    • Herbal Medicine
    • BPH
    • ADT: androgen deprivation tx
    • treatment side effects
    • Acapodene
    • Clinical trials
    • Clinical trial results
    • Vaccines
    • Brachytherapy
    • Vitamin-Mineral Supplements
    • Phenoxodiol
  • RSS feed
  • LINKS
    • Cancer Journals

      • Cancer Research (an AACR journal)
      • Clinical Cancer Research (an AACR Journal
    • Cancer Research

      • AACR
    • Environmental Health

      • Environmental Health Perspectives
    • Healthcare, insurance

      • Metastar
      • BenefitsCheckUpRx
      • Medicare & Prescription Help
      • Medicare
      • Eldercare locator
    • Home

      • PSA Rising
    • Medical Ethics

      • The Hutch "UNINFORMED CONSENT"
    • Nutrition

      • Consumer Lab Reviews
      • Dietary Supplements Info
      • Food Routes
      • nutrition.org
      • The New Farm
    • Prostate Cancer

      • Being a Patient (New York Times)
      • Free Multigraph
      • Fatigue
      • Angiogenesis section at Nature, 12/05
      • Terry Van Dyke's Lab
      • FDA > Trelstar
      • Xinlay - FDA review docs
      • My Cancer Blog - Daniel
      • WARRIOR GORD'S PCD
      • GRUPO DE APOYO PARA EL CANCER DE PROSTATA
      • Living with prostate cancer, a patient blog
      • Spanish Cancer Association
      • Prostate Action: Campaign is the Aim (UK)
      • Cycle for Life
      • San Jose Prostate Cancer Support Group
  • ARCHIVES
    • November 2006
    • October 2006
    • September 2006
    • July 2006
    • June 2006
    • May 2006
    • April 2006
    • March 2006
    • February 2006
    • January 2006
    • December 2005
    • November 2005
    • September 2005
  • Valid XHTML
  • XFN

Search just this blog

Join to add comments or your story

  • Register
  • Login

advertising

Eat to Beat Prostate Cancer Cookbook

Eat to Beat Prostate Cancer Cookbook Author: David Ricketts; buy New: $12.97

Intimacy with Impotence by Ralph Alterowitz

Intimacy with Impotence: The Couple's Guide to Better Sex after Prostate Disease by Ralph Alterowitz, Barbara Alterowitz. Price: $10.20

November 11, 2006

Protoxin trial for recurrent prostate cancer

category: Prostate Cancer, Cancer, Clinical trials posted by admin @ 5:22 am

Protoxin, also called PRX302, is a drug being tested on men with localized recurrent prostate cancer in Phase I clinical trials in Texas and Vermont.

Patients considering this trial must have experienced recurrence after completing a full course of definitive external beam radiation or definitive brachytherapy (but not both) as primary therapy for diagnosed prostate cancer at least one year prior to enrollment

Our main news about Protoxin is here:
PSA-activated protoxin that kills prostate cancer: phase I clinical trial is underway
http://www.psa-rising.com/prostatecancer/protoxin1106.htm

A reader asked for a simpler, clearer explanation of what’s going on with this drug. Here’s what we know at the moment:

In Texas, one trial enrolled the first patients in May this year and is hoping to recruit 36 men with localized recurrent prostate cancer. Patients must have recurred after EBR or brachytherapy, have PSA level less than 20 ng/mL and PSA doubling time longer than 3 months. They must NOT be taking hormone drugs. Also, they must NOT have signs of metastatic disease including no bone metastases on bone scan, or any lymph node, lung, liver or soft tissue.
(full story…)

Comment (0)
• • •

October 13, 2006

Phenoxodiol trials: focus on ovarian not prostate cancer

category: Prostate Cancer, Cancer, Clinical trials, Phenoxodiol posted by admin @ 9:36 pm

Phenoxodiol’s fast track status at FDA generates a lot on interest among men with advanced prostate cancer. But despite evidence that Phenoxodiol delays progression in hormone refractory prostate cancer, is the fast track to FDA approval petering out?
(full story…)

Comment (3)
• • •

October 1, 2006

Selenium Overdose Death

category: Prostate Cancer, Nutrition, Cancer, Clinical trials, Vitamin-Mineral Supplements posted by admin @ 11:40 am

An Australian man has died after swallowing 10,000 times the daily dose of selenium, reports The Age online newspaper. The 75-year-old mistakenly “purchased sodium selenite powder used primarily as a supplement for livestock, swallowing 10 grams.”

The man’s case is reported was reported October 2 in the Medical Journal of Australia (”Accidental death from acute selenium poisoning“).

According to The Age, Australian doctors who treated the 75-year-old “have used his death to highlight the dangers of promoting complementary medicines without adequate instructions.” The doctors blame the internet.

Selenium for human consumption, as sold in pharmacies, health stores and supermarkets , typically comes in 200 microgram (µg) pills or capsules, which may be printed “200 mcg.”
(full story…)

Comment (0)
• • •
PSA Rising: http://www.psa-rising.com